OGA and diabetes mellitus: For example, determine whether acute overexpression of O-GlcNAcase, which has been shown reverse some of the adverse effects of diabetes on cardiac function [14], would also reduce sarcolemmal FAT/CD36 levels thereby reverse the metabolic dysfunction.